24 results for “supply”
Almost six years since the law change, children still struggle to access a consistent supply of medicine in the UK, writes Matt Hughes, Medcan Family Foundation.
Astrasana and Clever Leaves have partnered to establish an international supply agreement for medical cannabis extracts in Czech Republic and Switzerland. Clever Leaves Holdings Inc, a global medicinal cannabis company, […]
The UK is poised to become Europe’s second largest medical cannabis market this year.
Business owners have raised £18,000 to fund Cole Thomson’s cannabis medicine throughout 2023.
Having the right software is a must, writes Miguel Fagundes, chief technical officer at Eurocan.
Patients prescribed cannabis for severe epilepsy will now have access to a UK supply of the Dutch oils.
Now is the time to redress perceptions of medicinal cannabis in the clinical community, says an expert.
UK patients will be able to access the medical cannabis oil Celixir20 until the end of the year.
The Department of Health has reached an agreement to continue the supply of Bedrocan oils
Medical cannabis patients report being left without medication, as supply issues become a “major concern” for the UK sector. A surge in demand for cannabis medicines, combined with the increased […]
A European pharmaceutical company – which focuses on drugs for the central nervous system (CNS) – has been selected to supply cannabis medicines for France’s landmark pilot study. Neuraxpharm France […]
Sponsored Feature Despite a temporary solution having been reached, the long-term future of children’s medical cannabis prescription remains in doubt. Sweet Pink CBD asks, what will the Government do to […]
Mother and prominent campaigner, Hannah Deacon has pleaded with the Prime Minister to help secure access to medical cannabis for her son and other patients. Hannah Deacon has been left […]
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
We take a closer look at the data behind medical cannabis prescribing to examine what it can reliably show us.
Two years on from the legalisation of medical cannabis in Ukraine, patients have received the first legal prescriptions for cannabis-based medicines.
Medical cannabis patients are often framed as consumers chasing the next strain, but that overlooks how many navigate treatment, writes Dave Barton.
A survey of more than 3,500 patients in Germany found that more than half were able to reduce their use of other medications.
Less than 100 patients have been approved for medical cannabis treatment under the MCAP scheme.
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
